“Safety evaluation of empagliflozin for patients with type 2 diabetes and chronic kidney disease”

Authors

Katherine Tuttle, ProvidenceFollow

Document Type

Presentation

Publication Date

10-1-2023

Keywords

washington; pmrc

Clinical Institute

Kidney & Diabetes

Comments

Video Journal of Biomedicine